Ovid Therapeutics, Inc. (OVID)
1.57
0.00 (0.00%)
USD |
NASDAQ |
Dec 10, 10:10
Ovid Therapeutics Total Liabilities (Quarterly): 19.15M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AnaptysBio, Inc. | 382.51M |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| MannKind Corp. | 539.19M |
| Cassava Sciences, Inc. | 48.16M |
| Cidara Therapeutics, Inc. | 96.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 63.85M |
| Shareholders Equity (Quarterly) | 44.70M |
| Debt to Equity Ratio | 0.3079 |
| Current Ratio | 4.241 |
| Net Debt Paydown Yield | 0.56% |